SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950142-24-001421
Filing Date
2024-05-24
Accepted
2024-05-24 16:46:31
Documents
2
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es240464224_3-eckelman.html 3  
1 OWNERSHIP DOCUMENT es240464224_3-eckelman.xml 3 1698
2 EXHIBIT 24.1 es240464224_ex2401.htm EX-24.1 10205
  Complete submission text file 0000950142-24-001421.txt   13510
Mailing Address C/O INHIBRX, INC. 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Eckelman Brendan P. (Reporting) CIK: 0001766433 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42031 | Film No.: 24985182

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)